3/A

MAIN DOCUMENT DESCRIPTION

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: November 23, 2004
Period of Report: May 27, 2004
Accession Number: 0001209191-04-054316

View Document ↗ View on SEC.gov ↗